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Objective: Thyroid hormones are crucial developmental factors and thyroid disease in pregnant women is a 
concern. Overweight and obesity are also important health concerns, and we hypothesized that in utero 
exposure to maternal thyroid disease could program the fetus to development of adiposity.
Design: Cohort and case-cohort studies
Participants: Pregnant women from the Danish National Birth Cohort and their 7-year old children. 
Measurements: Maternal thyroid disease (hyperthyroidism and hypothyroidism) was assessed from 
registrations of diagnoses and treatment (n = 71,706) or from the measurement of thyroid-stimulating 
hormone (TSH) in a stored blood sample from the early pregnancy (n = 7,624). Maternal pre-pregnancy 
body mass index (BMI) and child BMI at 7 years of age were used to define overweight and obesity, and 
associations were evaluated using regression models adjusting for potential confounders.
Results: No association was found between maternal thyroid disease in pregnancy and child overweight 
(hyperthyroidism: adjusted risk ratio (aRR): 1.02 (95%  confidence interval (CI): 0.58-1.82); 
hypothyroidism: 1.31 (0.86-1.97)) or obesity (hyperthyroidism: 0.96 (0.53-1.75); hypothyroidism: 1.25 
(0.76-2.05)). On the other hand, pregnant women with hypothyroidism in early pregnancy had a higher risk 
of being overweight (aRR: 1.20 (95%  CI: 1.03; 1.41)) and obese (1.45 (1.07; 1.96)), whereas women with 
hyperthyroidism had a lower risk of being overweight (0.79 (0.64; 0.98)).
Conclusions: Results provide no evidence that maternal thyroid disease in pregnancy programs adiposity 
in the child, but corroborate an association between maternal thyroid disease and adiposity in the mother. 
Key words 









This article is protected by copyright. All rights reserved
Introduction
Fetal development is a complex, tightly and timely regulated process, and an adequate level of thyroid 
hormones is important. Thyroid hormones present in the fetus in the early pregnancy originate from the 
mother, and this dependency emphasizes the importance of maternal thyroid function.1 Consequently, much 
concern is on thyroid disease in pregnant women which in turn could affect the supply of thyroid hormones 
to the fetus.2 The most important consequences of thyroid disease in pregnant women relate to the crucial 
role of thyroid hormones during brain development.1 Thus, a hypothesis of fetal programming by maternal 
thyroid disease via disturbed fetal brain development is biologically plausible and supported by 
experimental data.3 Thyroid hormones play a regulatory role in every cell in the human body, and the 
hypothesis of fetal programming by maternal thyroid disease may extend beyond brain development. 
Hence, it has been proposed that maternal thyroid disease may program the offspring to later development 
of asthma, cardiovascular disease, and metabolic alterations.4–7 Overweight and obesity are important 
health concerns and much attention is on the identification of risk factors.8 It has also been proposed that in 
utero exposures could program the fetus to abnormal body weight in later life.9,10 
We hypothesized that maternal thyroid disease in pregnancy could program the fetus to the development 
of adiposity in childhood. We evaluated the hypothesis among pregnant women and their 7-year-old 
children from the Danish National Birth Cohort (DNBC) using different designs and different markers of 
adiposity. Maternal body mass index (BMI)  is a strong determinant of BMI in the child,9 and maternal 
BMI could be a possible confounding factor in the association between maternal thyroid disease and child 
adiposity. Thus, we initially described the association between maternal thyroid disease and adiposity in the 
mother and subsequently included maternal BMI in the adjusted analyses on child outcomes.
Method and materials
Study design and population
The DNBC was established in Denmark from 1997-2003 and recruited 101,042 pregnancies in which the 
pregnant woman lived in Denmark and was able to participate in telephone interviews in Danish during the 
pregnancy.11 Participants in the present study were pregnant women from the DNBC who gave birth to a 
singleton, live-born child, and the woman’s first-born child during the study period was included. 
Furthermore, the participants all had a blood sample drawn in the early pregnancy weeks. A total of 71,706 
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The DNBC also included the biochemical measurement of maternal thyroid function in early pregnancy 
within a 12% random sample of the source population (Fig. 1).12,13 Thus, participants from the source 
population and from the random sample were included for assessment of maternal (Fig. 1, part I) and child 
health (Fig. 1, part II). 
Maternal health was assessed in cross-sectional studies that evaluated the association between maternal 
thyroid disease and maternal adiposity (Fig. 1, part I). These studies included all pregnant women from the 
source population with available data on pre-pregnancy BMI (Fig. 1, part Ia) as well as all pregnant women 
from the  random sample who had information on pre-pregnancy BMI and biochemical assessment of 
thyroid function in pregnancy (Fig. 1, part Ib). 
Child health was assessed in cohort studies and in a case-cohort study (Fig. 1, part II). The DNBC 
included a 7-year follow-up of the children in which the parents were asked to fill out a questionnaire about 
the child. The age of the child at follow-up ensured the possibility to cover the pre-school age since 
children in Denmark on average start elementary school at 7 years of age. Overall, the rate of participation 
in this follow-up was 60-65%, and a total of 43,073 pregnant women from the source population 
participated in the follow-up when the child was median 7.1 years old (range 7.0 to 7.99 years).14 In the 
present study, children who participated in this follow-up and had available data on BMI were included in a 
cohort study (Fig. 1, part IIa). Similarly were children whose mother was part of the random sample and 
had thyroid function assessed in early pregnancy (Fig. 1, part IIb). Finally, a case-cohort study was 
performed in which all children in the source population with a BMI corresponding to obesity at 7 years of 
age were included (cases) together with individuals from the 12% random sample (sub-cohort) (Fig. 1, part 
IIc). 
Exposure 
In part Ia and IIa (Fig. 1), maternal thyroid disease was assessed from nationwide health registers and from 
a telephone interview in the early pregnancy. The Danish National Hospital Register (DNHR) holds 
information on all in- and outpatients hospital visits including diagnoses of disease coded according to the 
International Classification of Disease (8th edition from 1977-1993; 10th edition from 1994 and onwards). 
The Danish National Prescription Register (DNPR) holds information on all prescriptions of drugs 
redeemed from Danish pharmacies from 1995 including the type of drug coded according to the anatomical 
therapeutic classification. As previously described in detail,15 information on maternal thyroid disease was 
obtained before, during and up to five years after the pregnancy and the different registrations were 
combined to classify maternal hyperthyroidism and hypothyroidism and the onset of disease. 
In part Ib, IIb and IIc (Fig. 1), maternal thyroid disease was assessed from the measurement of thyroid-
stimulating hormone (TSH) in a stored blood sample from the early pregnancy. The blood sample had been 
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thawed in the year 2015 for the measurement of TSH using a Dimension Vista automated immunoassay 
(Siemens Healthineers, Germany), as previously described in detail.12 Thyroid hormones are considered 
stable during long-term storage and freezing/thawing.16 Maternal thyroid disease was classified according 
to the method- and pregnancy week-specific reference ranges previously established within the cohort.12 
We a priori decided to focus our hypothesis and the analyses on maternal thyroid disease defined by TSH 
alone.17 Hyperthyroidism was defined by a TSH below the pregnancy week-specific 2.5 percentile and 
hypothyroidism by a TSH above the 97.5 percentile. In a sub-analyses, associations were evaluated 
according to the severity of maternal thyroid disease defined by the level of TSH in early pregnancy. 
Outcome 
Maternal pre-pregnancy BMI and child BMI at 7 years of age were calculated as body weight in kilograms 
(kg) divided by the height in meters squared (m2). Information on maternal height and weight was assessed 
from the self-reported information in the early pregnancy interview and 70,487 pregnant women from the 
source population had available data on BMI (Fig. 1, part Ia). Maternal BMI ≥ 25.0 kg/m2 was the main 
outcome measure, which combined overweight and obesity. Maternal obesity (BMI ≥ 30.0 kg/m2) was less 
frequent, but also evaluated in a sub-analysis. 
The parents reported information on the latest measured height and weight of the child at 7 years of age 
and 40,585 children had available data for calculation of BMI (Fig.1 , part IIa). The measurements were 
made by the school doctor, public health nurse, general practitioner or the parent, and the validity is found 
to be high.9,18 Among children with available data on BMI, the mean BMI (15.7 kg/m2) and standard 
deviation (1.7 kg/m2) was used for individual calculation of BMI z-score by subtracting the population 
mean BMI from the individual BMI and dividing the difference with the standard deviation of the 
population.9 Child BMI was quite similar among boys and girls in this study population and the age of the 
children was within a narrow range. Consequently, z-scores were not calculated within sex and age strata. 
Child overweight was defined by a BMI > 18 kg/m2, which is the internationally recommended cut-point at 
7 years of age for both girls and boys corresponding to a BMI of 25 kg/m2 at age 18 years.19 This cut-point 
corresponded to the 90th percentile in the study population and combined child overweight and obesity. 
Child obesity was defined by a BMI > 21 kg/m2, which is the internationally recommended cut-point at 7 
years of age for both girls and boys corresponding to a BMI of 30 kg/m2 at age 18 years.19 This cut-off 
corresponded to the 99th percentile in the study population. Child obesity was less frequent and this 
outcome was evaluated using the case-cohort design. This design allowed for the inclusion of all cases of 
obesity in the full cohort and comparison to a random sub-cohort. In addition to weight and height, the 
parents reported on child waist circumference (WC) in centimeters (cm) at 7 years of age and this 
secondary outcome was also assessed among children with available information (part IIa: n = 37,131, part 
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Covariates
Information on covariates was obtained from the DNBC interviews in the pregnancy (maternal smoking 
and pre-pregnancy alcohol intake), from the Danish Medical Birth Register (maternal age, parity, child’s 
sex, gestational age at birth, and birth weight), from Statistics Denmark (maternal country of birth, 
geographical residence, and educational level), and from the DNHR and DNPR (maternal diabetes mellitus 
before, during and up to five years after the pregnancy). 
Statistical analyses
Linear regression was used to estimate crude and adjusted mean differences (MD) for the association 
between maternal hyper- and hypothyroidism and outcomes of maternal BMI and child BMI z-score as 
well as child WC. Results of the linear regression models were robust against non-normality and variance 
heterogeneity when bootstrapping was applied. Modified Poisson regression was used to estimate crude and 
adjusted risk ratios (RR) for the association between maternal hyper- and hypothyroidism and outcomes of 
maternal and child overweight and obesity.20 Finally, the method for analyses of case-cohort studies with 
binary outcome described by Schouten et al. was used to estimate crude and adjusted RR for the association 
between maternal hyper- and hypothyroidism and the outcome of child obesity.21 Child’s sex, birth weight, 
and gestational age at birth were not included in the main adjusted model, but considered separately in a 
sub-analysis. To substantiate the findings, median maternal TSH within non-overweight, overweight and 
obese pregnant women and children, respectively, were estimated and compared using Mann-Whitney U 
test. 
All participating mothers provided written informed consent. The study was approved by The North 
Denmark Region Committee on Health Research Ethics (N-20130054), the Danish Data Protection 
Agency (2008-58-0028) and the DNBC Steering Committee (2013-23). Statistical analyses were performed 
using STATA 16 (Stata Corp., College Station, Texas, USA).
Results
Altogether 70,487 pregnant women were included in early pregnancy for maternal health assessment (Fig 
1, part I), and 40,585 of the women were included in the follow-up investigation on health of the child at 7 
years of age (Fig. 1, part II). These groups of women were comparable on the majority of maternal 
characteristics (Table 1), however, there was a tendency towards higher age and educational level in the 
follow-up population. 
For the association between maternal thyroid disease and adiposity (Table 2), maternal hypothyroidism 
as defined from diagnosis and treatment (part Ia) was associated with a higher BMI and a higher risk of 
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hypothyroidism at the time of pregnancy (Table 2, part Ia). Altogether 7,504 pregnant women had thyroid 
function assessed in the early pregnancy from the measurement of TSH (Table 2, part Ib). In this group, 
maternal TSH was median 1.19 mIU/l in non-overweight women and higher in women (n = 2,053) with 
overweight (median 1.31 mIU/l, p < 0.001) as well as in women (n = 628) with obesity (median 1.38 
mIU/l, p < 0.001). When maternal hyper- and hypothyroidism were defined from TSH in early pregnancy 
(Table 2, part Ib), an association between hypothyroidism and BMI was corroborated. Moreover, 
hyperthyroidism was associated with a lower BMI and a lower risk of overweight (Table 2, part Ib). 
For the association between maternal thyroid disease and child adiposity defined by BMI at 7 years of 
age (Table 3 and 4), no association was observed except that maternal hypothyroidism diagnosed after the 
pregnancy marginally associated with a higher BMI z-score in the child (Table 3, part IIa). Altogether 
4,255 of the randomly selected pregnant women had thyroid function in the early pregnancy assessed from 
the measurement of TSH (Table 3, part IIb). In this group, maternal TSH was median 1.21 mIU/l in non-
overweight children and similar in children (n = 318) with overweight (median 1.24 mIU/l, p = 0.4). 
Furthermore, the case-cohort study included 372 obese children (Table 5, part IIc) and maternal TSH in this 
group was median 1.29 mIU/l and not different from the random sub-cohort (median 1.21 mIU/l, p = 0.4).
Similar to child BMI, no associations between maternal thyroid disease and child WC at 7 years of age 
was found (Table 5). The association between maternal thyroid disease and markers of adiposity in the 
child did not change when child’s sex, gestational age, and birth weight were considered in the analyses. 
Furthermore, results did not change when the severity of maternal thyroid disease was considered from the 
level of TSH in early pregnancy. 
Discussion 
Principal findings
This study evaluated the association between maternal thyroid disease in pregnancy and markers of 
maternal and child adiposity within a large, well-defined and nationwide cohort. Across the different 
designs, no substantial evidence was found that maternal thyroid disease programs adiposity in the child at 
7 years of age. However, an association between maternal thyroid disease and markers of adiposity in the 
mother was seen. 
Adiposity in the mother
The topic of thyroid disease and body weight has long attracted attention from clinicians and scientists. 
From patient complaints and clinical observations of changes in body weight before and after the treatment 
of thyroid disease to the scientific curiosity about the underlying mechanisms.22 In line with our findings, it 
has been observed in non-pregnant and in pregnant individuals that BMI is higher in patients suffering from 
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loss after treatment of hypothyroidism and weight gain after treatment of hyperthyroidism are often seen in 
clinical practice and in observational studies.22,26 However, even when associations are consistently 
observed, the difficult part is on the determination of the underlying mechanisms and causality. Our 
investigation on maternal health was cross-sectional and relied on maternal pre-pregnancy BMI and 
assessment of maternal thyroid disease from indirect measures or from a single biochemical measurement 
of thyroid function in early pregnancy. Self-reported pre-pregnancy BMI has been shown to correlate well 
with measured BMI and with BMI at the first antenatal visit in pregnancy.27,28 Considering thyroid disease, 
we previously showed that a large proportion of women diagnosed with thyroid disease after the pregnancy 
had abnormal biochemical thyroid function in the early pregnancy.13 This observation suggests that the 
thyroid function abnormality identified in early pregnancy was likely to persist and to reflect actual thyroid 
disease. On the other hand, women with known thyroid disease diagnosed before the pregnancy may be 
insufficiently treated in pregnancy,13 and we observed an association with maternal adiposity in this group 
specifically. We had only markers of thyroid disease and adiposity in pregnancy, and we cannot determine 
the direction of the association observed. This relationship is also not clear from studies in non-pregnant 
individuals, and it is a notable finding that thyroid disease may affect weight status, but also that obesity 
potentially affects thyroid function.22 Furthermore, the higher body weight in hypothyroid individuals and 
the weight loss associated with treatment seem related to water excess and subsequent water loss and not a 
higher content of fat.22,26 One may speculate how the physiological alterations in body composition during a 
pregnancy interact with this hypothesis. 
Another aspect relates to the clinical implications of an association between thyroid disease and body 
weight. For the management of thyroid disease in pregnancy, it remains uncertain if the diagnostic 
procedure would benefit from the use of reference ranges for thyroid function tests that are stratified by 
categories of maternal BMI.12,29 Moreover, measurement of TSH should be considered in clinical practice 
when maternal BMI is above 40 kg/m2 (morbid obesity).2 A scientific consideration is also on the 
establishment of reference ranges for thyroid function tests and the potential influence of maternal BMI on 
reports of prevalence and incidence of maternal thyroid disease in pregnancy. Furthermore, considerations 
are on the possible implications for pregnancy outcome studies. Much focus is on fetal programming by 
maternal obesity and various outcomes of pregnancy and child development have been investigated.9,10 
Thus, studies investigating the consequences of maternal thyroid disease in pregnancy should preferably 
include data on maternal body weight and height.  
Adiposity in the child
The concept of fetal programming by in utero exposure has long been considered and is yet still emerging.3 
A fetal programming effect of maternal thyroid disease in pregnancy has mainly been proposed in relation 
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child.3 Such hypothesis is supported by experimental data and by clinical data from women with severe 
overt abnormalities in thyroid function.17 On the other hand, the impact of smaller abnormalities in 
maternal thyroid function on child neurocognitive development is not clear.17 
The hypothesis of fetal programming by maternal thyroid disease has also been proposed in relation to 
metabolic and cardiovascular outcomes in the offspring. Considering the diverse role of thyroid hormones 
in humans and during development it can be hypothesized that peripheral metabolic effects as well as 
alterations of central hormonal regulation may play a role.30,31 Thus, experimental data have proposed an 
association and observational studies within birth cohorts from Denmark, the Netherlands, and the United 
Kingdom have investigated the hypothesis in humans.4,5,7 Notably, previous results were not consistent, and 
studies were heterogeneous in terms of design, exposure, and outcome assessment. The timing of exposure 
assessment in early pregnancy varied from early to late pregnancy and the age of the child at outcome 
evaluation ranged from 6 to 20 years.4,5,7 Furthermore, it varied between studies whether variation in 
maternal thyroid function within the normal range or deviations outside the reference ranges were 
considered.4,5,7 
An association between maternal thyroid function and blood pressure in the offspring was observed in 
two studies,4,5 and one study found that lower levels of maternal TSH in early pregnancy associated with 
lower BMI in the child at 6 years of age as well as lower abdominal subcutaneous fat mass area and total 
fat mass.4 Contrary to this report4  and in line with other reports,5,7 we observed no association between 
maternal thyroid disease in pregnancy and child BMI at 7 years of age. We used various methods to 
identify maternal hyper- and hypothyroidism in pregnancy and regardless of the method used, the 
association between maternal hyperthyroidism and markers of adiposity in the child was robust with point 
estimates being close to no effect. We also found no effect of maternal hypothyroidism, however, results 
for this type of thyroid disease varied to some extent by the method of exposure assessment, and the 
adjusted RR for overweight and obesity in the child were slightly above one, but non-significant. We 
previously showed that marked maternal hypothyroidism in early pregnancy (TSH above 10 mIU/l) was 
associated with lower intelligence quotient in the child at 6 years of age.32 However, results of the present 
study did not change when the severity of maternal hypothyroidism was considered. A strength of our study 
was the comprehensive information on maternal characteristics and the possibility to adjust for potential 
confounders including maternal BMI. Furthermore, the case-cohort design is feasible to study rare 
outcomes, and the fact that we observed no association between maternal thyroid disease and child obesity 
even using this design provides evidence of no association. Thus, the findings may favor a scientific focus 
on alternative hypotheses and other outcomes of child development. 
The definition of child obesity may be inconsistent across studies and international guidelines. We used 
the 99th percentile of BMI to define child obesity, which corresponded to an internationally recommended 
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identified were severely obese, and we cannot exclude that an association would be seen with less severe 
obesity. Notably, our findings were consistent when WC was used as a different marker of adiposity in the 
child. BMI is the most commonly used marker of adiposity, but other markers are increasingly used, and 
the predictive role of different markers on the risk of cardiovascular disease and metabolic syndrome is 
considered in children and in adults.34 Furthermore, it is considered how these indirect markers correlate 
with more direct measures of body fat content and distribution.34 We cannot exclude that an association 
between maternal thyroid disease and alternative markers of child adiposity would be seen. Furthermore, 
we had no information on thyroid function in the child which would be of interest considering that both 
maternal thyroid function and obesity have been associated with alterations in offspring thyroid function.35 
Finally, thyroid disease in women of fertile age are predominantly of autoimmune origin,2 and it remains 
uncertain whether autoimmune mechanism could be involved in a fetal programming effect. No 
measurements of thyroid autoantibodies were performed in this study and would be of interest in future 
investigations. 
Conclusion
In a Danish nationwide birth cohort, various investigations using different designs provided no evidence 
that maternal thyroid disease programs adiposity in the child. Results corroborated an association between 
maternal thyroid disease in pregnancy and adiposity in the mother and call for further studies to address the 
clinical impact of deviations in body weight among women with thyroid disease who are or may become 
pregnant. These findings inform the debate on the management of thyroid disease in pregnant women 
including the consequences of abnormal maternal thyroid function for later development of the child and 
considerations on how and when to diagnose thyroid disease in pregnant women.   
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Table 1 Maternal characteristics at time of the pregnancy among women from the 
source population (part Ia) and among the women who participated in the 7-year 




































aIndividuals with missing information on country of birth (study part Ia: n = 19; study part IIa: n = 8), geographical 
residence (n = 236; n = 50), educational level (n = 242; n = 77), smoking in pregnancy (n = 22; n = 13), and pre-
pregnancy alcohol intake (n = 93; n = 45) were not included in the table.  
bDivided by the Great Belt.  




 Part Ia  Part IIa 
 n % n % 
Pregnant womena  70,487  40,585  
Year of child’s birth     
1997-2000 41,769 59.3 24,450 60.2 
2001-2003 28,718 40.7 16,135 39.8 
Age at child’s birth     
< 30 years 34,591 49.1 19,229 47.4 
≥ 30 years 35,896 50.9 21,356 52.6 
Previous births     
Nulliparous 35,338 50.1 20,597 50.8 
Multiparous 35,149 49.9 19,988 49.2 
Country of birth     
Denmark 68,918 97.8 39,808 98.1 
Outside Denmark 1,550 2.2 769 1.9 
Geographical residenceb     
East Denmark 27,237 38.8 15,571 38.4 
West Denmark 43,014 61.2 24,964 61.6 
Educational level      
Low 16,016 22.8 8,009 19.8 
Middle 28,673 40.8 16,261 40.1 
High 25,556 36.4 16,238 40.1 
Smoking in pregnancy     
Yes 19,016 27.0 9,780 24.1 
No 51,449 73.0 30,792 75.9 
Pre-pregnancy body mass index     
< 18.5 kg/m2 3,205 4.5 1,694 4.2 
18.5-24.9 kg/m2 47,882 67.9 28,410 70.0 
25.0-29.9 kg/m2 13,639 19.4 7,583 18.7 
≥ 30.0 kg/m2 5,761 8.2 2,898 7.1 
Pre-pregnancy alcohol intake     
0-7 units/week 64,049 91.0 36,871 91.0 
> 7 units/week 6,345 9.0 3,669 9.0 
Diabetes mellitusc     
Yes 2,009 2.8 1,079 2.7 
No 68,478 97.2 39,506 97.3 
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Table 2 Association between maternal thyroid disease and maternal pre-pregnancy body mass index (BMI). Maternal thyroid disease was assessed from 
hospital diagnosis and redeemed prescriptions of drugs (part Ia) and from biochemical measurement of thyroid function in thearly pregnancy (part Ib).
Abbreviations: cMD: crude mean difference; aMD: adjusted mean difference;  cRR: crude risk ratio; aRR: adjusted risk ratio; CI: confidence interval; ref.: reference group.
aBMI ≥ 25.0 kg/m2.
bBMI ≥ 30.0 kg/m2.
cAdjusted model included: year of child’s birth, maternal age, parity, country of birth, geographical residence, educational level, smoking in pregnancy, pre-pregnancy alcohol intake, and diabetes mellitus.
d95% confidence interval for the adjusted estimate.
BMI (kg/m2) Mean difference in BMI Risk ratio for overweighta Risk ratio for obesityb
n Mean cMD aMDc 95% CId cRR aRRc 95% CId cRR aRRc 95% CId
Part Ia 70,487
Non-exposede 68,529 23.5 Ref. Ref. Ref. Ref. Ref. Ref.
Hyperthyroidism 1,113 23.7 0.11 -0.09 -0.33; 0.16 1.08 1.01 0.93; 1.11 1.19 1.08 0.90; 1.29
Before or during pregnancy 615 23.6 0.06 -0.15 -0.49; 0.18 1.03 0.63 0.84; 1.09 1.16 1.04 0.81; 1.32
After pregnancy 498 23.7 0.17 -0.01 -0.37; 0.36 1.14 1.09 0.95; 1.23 1.21 1.12 0.86; 1.46
Hypothyroidism 845 24.3 0.74 0.64 0.36; 0.93 1.24 1.21 1.10; 1.33 1.40 1.34 1.11; 1.63
Before or during pregnancy 362 24.8 1.24 1.09 0.66; 1.52 1.39 1.33 1.17; 1.53 1.67 1.58 1.21; 2.07
After pregnancy 483 23.9 0.37 0.31 -0.06; 0.69 1.13 1.12 0.98; 1.27 1.20 1.16 0.88; 1.52
Part Ib 7,504
Non-exposedf 6,884 23.6 Ref. Ref. Ref. Ref. Ref. Ref.
Hyperthyroidism 270 23.1 -0.45 -0.61 -1.12; -0.10 0.84 0.79 0.64; 0.98 0.90 0.80 0.52; 1.23
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eNo registration of maternal hyper- or hypothyroidism up to 5 years after the pregnancy. 
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Table 3 Association between maternal thyroid disease and body mass index (BMI) of the child at 7-years 
of age. Maternal thyroid disease was assessed from hospital diagnosis and redeemed prescriptions of 
drugs (part IIa) and from biochemical measurement of thyroid function in the early pregnancy (part IIb).
Abbreviations: cMD: crude mean difference; aMD: adjusted mean difference;  cRR: crude risk ratio; aRR: adjusted risk ratio; CI: confidence 
interval; ref.: reference group.
aBMI > 18.0 kg/m2.
bAdjusted model included: year of child’s birth, maternal age, parity, country of birth, geographical residence, educational level, smoking in 
pregnancy, pre-pregnancy alcohol intake, pre-pregnancy BMI, and diabetes mellitus.
c95% confidence interval for the adjusted estimate. 
dNo registration of maternal hyper- or hypothyroidism up to 5 years after the pregnancy. 
eTSH within the method- and pregnancy week-specific reference range. 
BMI  (kg/m2) Mean difference in BMI z-score Risk ratio for overweighta
n Mean cMD aMDb 95% CIc cRR aRRb 95% CIc
Part IIa 40,585
Non-exposedd 39,466 15.7 Ref. Ref. Ref. Ref.
Hyperthyroidism 625 15.7 -0.01 -0.04 -0.12; 0.04 1.07 0.99 0.78; 1.27
Before or during pregnancy 343 15.6 -0.03 -0.07 -0.17; 0.04 0.99 0.88 0.63; 1.24
After pregnancy 282 15.7 0.01 -0.01 -0.13; 0.10 1.17 1.14 0.80; 1.62
Hypothyroidism 494 15.9 0.13 0.10 0.01; 0.18 1.18 1.12 0.86; 1.46
Before or during pregnancy 202 15.8 0.06 -0.01 -0.14 0.13 1.09 0.96 0.62; 1.50
After pregnancy 292 16.0 0.18 0.16 0.05; 0.28 1.25 1.24 0.89; 1.72
Part IIb 4,255
Non-exposede 3,889 15.6 Ref. Ref. Ref. Ref.
Hyperthyroidism 156 15.5 -0.10 -0.10 -0.25; 0.06 0.96 1.02 0.58; 1.82
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Table 4 Association between maternal thyroid disease and obesity in the child at 7 years of age in a case-
cohort study (part IIc). Maternal thyroid disease was assessed from biochemical measurement of thyroid 
function in the early pregnancy.
Abbreviations: cRR: crude risk ratio; aRR: adjusted risk ratio; CI: confidence interval; ref.: reference group
aBMI > 21.0 kg/m2.
bAdjusted model included: year of child’s birth, maternal age, parity, country of birth, geographical residence, educational level, smoking in 
pregnancy, pre-pregnancy alcohol intake, pre-pregnancy body mass index, and diabetes mellitus.
c95% confidence interval for the adjusted estimate.
dTSH within the method- and pregnancy week-specific reference range. 
Sub-cohort Cases Risk ratio of obesitya
n % n % cRR aRRb 95% CIc
Part IIc 4,255 372
Non-exposedd 3,889 91.4 336 90.3 Ref. Ref.
Hyperthyroidism 156 3.7 13 3.5 0.96 0.96 0.53; 1.75
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Table 5 Association between maternal thyroid disease and waist circumference (WC) of the 
child at 7 years of age. Maternal thyroid disease was assessed from hospital diagnosis and 
redeemed prescriptions of drugs (part IIa) and from biochemical measurement of thyroid 
function in the early pregnancy (part IIb).
Abbreviations: WC: waist circumference; cMD: crude mean difference; aMD: adjusted mean difference;  CI: confidence interval; 
ref.: reference group.
aAdjusted model included: year of child’s birth, maternal age, parity, country of birth, geographical residence, educational level, 
smoking in pregnancy, pre-pregnancy alcohol intake, pre-pregnancy B, and diabetes mellitus.
b95% confidence interval for the adjusted estimate. 
cNo registration of maternal hyper- or hypothyroidism up to 5 years after the pregnancy. 
dTSH within the method- and pregnancy week-specific reference range. 
WC (cm) Mean difference in WC
n Mean cMD aMDa 95% CIb
Part IIa 37,131
Non-exposedc 36,128 57.0 Ref. Ref.
Hyperthyroidism 564 57.2 0.16 0.06 -0.35; 0.47
Before or during pregnancy 308 57.1 0.08 -0.04 -0.59; 0.51
After pregnancy 256 57.3 0.25 0.17 -0.43; 0.77
Hypothyroidism 439 57.5 0.42 0.26 -0.20; 0.72
Before or during pregnancy 177 57.5 0.49 0.24 -0.49; 0.96
After pregnancy 262 57.4 0.37 0.28 -0.32; 0.87
Part IIb 3,872
Non-exposedd 3,544 56.9 Ref. Ref.
Hyperthyroidism 138 56.4 -0.50 -0.38 -1.18; 0.43
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Figure legends
Fig. 1 Flowchart illustrating the selection of the study population within the Danish National Birth Cohort 
for the study on maternal health assessment (part I) and child health assessment (part II).  
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